A 30-day supply of Sotyktu is $743 on TrumpRx, down from an original price of $7,135.55. The federal drug-discount site lists Bristol Myers Squibb’s 6 mg tablets under that figure on its Presidential deals page, with a savings of $6,392.55 and a label of 90 percent off. The Sotyktu page calls the amount an out-of-pocket price, which raises a plain question for anyone with drug coverage: does it beat what the plan already charges?
What Sotyktu is and what the page shows
Sotyktu is a pill from Bristol Myers Squibb. The company’s own Sotyktu site says it treats adults with moderate-to-severe plaque psoriasis who may benefit from systemic therapy, and adults with active psoriatic arthritis. It comes in one strength, 6 mg.
The TrumpRx product page lists a package of 30 tablets at $743.00 against $7,135.55. Orders are handled by BMS Patient Connect, the company’s direct-pay service, which the page lists at 1-800-332-2056. The price is shown as a starting price, so the final figure for a given prescription could differ.
That works out to about $24.77 a tablet at the TrumpRx price, against roughly $237.85 a tablet at the original price. Those per-tablet numbers are arithmetic on the listed totals, not figures the site publishes.
For people on Medicare, a $743 monthly cash price for Sotyktu has to be weighed against Part D, where covered-drug spending stops at $2,100 a year in 2026. The Medicare Cost & Coverage Protection Kit includes the new Part D out-of-pocket cap and 51 state Medicare cost-help packs.
Where $743 sits among the other listings
The browse page shows 80 medications across five pages, and Sotyktu appears among the first 16. The discounts vary a lot. Plavix is listed at $15.95 against $771.62, and Combigan at $10 against $204.13. Wegovy in pill form is $149 against $1,349.02. Humira, in pen or syringe form, is $950 against $6,922.62.
Sotyktu is the second-priciest of those examples after Humira. At $743 a month, a year of it would come to $8,916 if the price held, which is more than the $2,100 yearly out-of-pocket limit that Medicare puts on covered Part D drugs in 2026.
Why the label says out-of-pocket
The page states that $743 is an out-of-pocket price. That means money paid directly, without a health plan processing the claim. For a person who has no drug coverage, or whose plan does not cover Sotyktu, that can be a real option. For a person whose plan does cover it, the plan’s own copay or coinsurance is the number to compare.
The page does not say whether the direct purchase counts toward a plan’s deductible or toward Medicare’s yearly cap. Neither TrumpRx nor Bristol Myers Squibb has said so on the pages that list the drug. The question belongs with the plan’s member services line before any money changes hands.
The Part D numbers behind the comparison
According to Medicare.gov, catastrophic coverage starts once out-of-pocket spending on covered Part D drugs reaches $2,100 in 2026, and $2,400 in 2027. No Medicare drug plan may have a deductible above $615 in 2026. A plan that covers Sotyktu would charge somewhere inside those limits, depending on its tier, which is why the copay for the exact drug and exact pharmacy is worth getting in writing.
People with limited income may qualify for more help. Medicare.gov says Extra Help applies automatically to anyone with full-benefit Medicaid, a Medicare Savings Program or SSI. For 2026, others generally need income under $23,940 and resources under $18,090 as an individual, or $32,460 and $36,100 as a couple.
Comparing a cash price with a plan’s copay
The comparison takes three numbers. The first is the plan’s copay or coinsurance for Sotyktu, which a pharmacist can find by running the prescription as a test claim. The second is the TrumpRx price, $743 for 30 tablets. The third is how much of the year’s out-of-pocket total has already been spent, because a plan that has nearly hit the cap changes the math.
The free sources are the product page at trumprx.gov/p/sotyktu, the plan’s drug list and Medicare’s own pages. A State Health Insurance Assistance Program counselor can walk through a plan for free, and 1-800-MEDICARE handles general questions.
A prescriber should confirm the dose and the condition before anything is bought. The listing is for the 6 mg, 30-count package only.
A $743 pill against a $2,100 yearly limit
Paying $743 a month in cash when a plan would have charged far less is the costly way to get this wrong, and so is missing the state help that cuts drug bills. The Medicare Cost & Coverage Protection Kit puts the new Part D out-of-pocket cap and 51 state Medicare cost-help packs in one 15-page kit.
Compare a Sotyktu cash price with Part D costs in the Medicare Cost & Coverage Protection Kit →
This article was produced with AI assistance and edited for accuracy against the sources linked above.
